Pharmaceuticals

Europe T-Cell Immunotherapy Market Report 2017

  • QYR908506
  • 122 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of T-Cell Immunotherapy

Revenue, means the sales value of T-Cell Immunotherapy

This report studies sales (consumption) of T-Cell Immunotherapy in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Adaptimmune

Altor Bioscience Corporation

Cellectis

Cell Therapy Catapult

Juno Therapeutics

Kite Pharma

Novartis

Takara Bio

Unum Therapeutics

Abingworth

ARCH Venture Partners

Acorn Campus Ventures

Adaptimmune

AFA F?rs?kring

AGF Private Equity

AgonOx

Agreen Biotech

Aju IB Investment

Alaska Permanent Fund

Alexandria Ventures

Allos Therapeutics

Amgen

Applied Immune Technologies

Aquilo Capital Management

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of T-Cell Immunotherapy in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

CAR-T

TCR

TIL Therapies

Split by application, this report focuses on sales, market share and growth rate of T-Cell Immunotherapy in each application, can be divided into

Hematological Malignancies

Solid Tumors

Others

Table of Contents

Europe T-Cell Immunotherapy Market Report 2017

1 T-Cell Immunotherapy Overview

1.1 Product Overview and Scope of T-Cell Immunotherapy

1.2 Classification of T-Cell Immunotherapy

1.2.1 CAR-T

1.2.2 TCR

1.2.3 TIL Therapies

1.3 Application of T-Cell Immunotherapy

1.3.1 Hematological Malignancies

1.3.2 Solid Tumors

1.3.3 Others

1.4 T-Cell Immunotherapy Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of T-Cell Immunotherapy (2012-2022)

1.5.1 Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2022)

1.5.2 Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 Europe T-Cell Immunotherapy by Manufacturers, Type and Application

2.1 Europe T-Cell Immunotherapy Market Competition by Manufacturers

2.1.1 Europe T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe T-Cell Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe T-Cell Immunotherapy (Volume and Value) by Type

2.2.1 Europe T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)

2.2.2 Europe T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)

2.3 Europe T-Cell Immunotherapy (Volume and Value) by Countries

2.3.1 Europe T-Cell Immunotherapy Sales and Market Share by Countries (2012-2017)

2.3.2 Europe T-Cell Immunotherapy Revenue and Market Share by Countries (2012-2017)

2.4 Europe T-Cell Immunotherapy (Volume) by Application

3 Germany T-Cell Immunotherapy (Volume, Value and Sales Price)

3.1 Germany T-Cell Immunotherapy Sales and Value (2012-2017)

3.1.1 Germany T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

3.1.2 Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

3.1.3 Germany T-Cell Immunotherapy Sales Price Trend (2012-2017)

3.2 Germany T-Cell Immunotherapy Sales and Market Share by Manufacturers

3.3 Germany T-Cell Immunotherapy Sales and Market Share by Type

3.4 Germany T-Cell Immunotherapy Sales and Market Share by Application

4 France T-Cell Immunotherapy (Volume, Value and Sales Price)

4.1 France T-Cell Immunotherapy Sales and Value (2012-2017)

4.1.1 France T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

4.1.2 France T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

4.1.4 France T-Cell Immunotherapy Sales Price Trend (2012-2017)

4.2 France T-Cell Immunotherapy Sales and Market Share by Manufacturers

4.3 France T-Cell Immunotherapy Sales and Market Share by Type

4.4 France T-Cell Immunotherapy Sales and Market Share by Application

5 UK T-Cell Immunotherapy (Volume, Value and Sales Price)

5.1 UK T-Cell Immunotherapy Sales and Value (2012-2017)

5.1.1 UK T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

5.1.2 UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

5.1.5 UK T-Cell Immunotherapy Sales Price Trend (2012-2017)

5.2 UK T-Cell Immunotherapy Sales and Market Share by Manufacturers

5.3 UK T-Cell Immunotherapy Sales and Market Share by Type

5.4 UK T-Cell Immunotherapy Sales and Market Share by Application

6 Russia T-Cell Immunotherapy (Volume, Value and Sales Price)

6.1 Russia T-Cell Immunotherapy Sales and Value (2012-2017)

6.1.1 Russia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

6.1.2 Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

6.1.6 Russia T-Cell Immunotherapy Sales Price Trend (2012-2017)

6.2 Russia T-Cell Immunotherapy Sales and Market Share by Manufacturers

6.3 Russia T-Cell Immunotherapy Sales and Market Share by Type

6.4 Russia T-Cell Immunotherapy Sales and Market Share by Application

7 Italy T-Cell Immunotherapy (Volume, Value and Sales Price)

7.1 Italy T-Cell Immunotherapy Sales and Value (2012-2017)

7.1.1 Italy T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

7.1.2 Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

7.1.7 Italy T-Cell Immunotherapy Sales Price Trend (2012-2017)

7.2 Italy T-Cell Immunotherapy Sales and Market Share by Manufacturers

7.3 Italy T-Cell Immunotherapy Sales and Market Share by Type

7.4 Italy T-Cell Immunotherapy Sales and Market Share by Application

8 Spain T-Cell Immunotherapy (Volume, Value and Sales Price)

8.1 Spain T-Cell Immunotherapy Sales and Value (2012-2017)

8.1.1 Spain T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

8.1.2 Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

8.1.8 Spain T-Cell Immunotherapy Sales Price Trend (2012-2017)

8.2 Spain T-Cell Immunotherapy Sales and Market Share by Manufacturers

8.3 Spain T-Cell Immunotherapy Sales and Market Share by Type

8.4 Spain T-Cell Immunotherapy Sales and Market Share by Application

9 Benelux T-Cell Immunotherapy (Volume, Value and Sales Price)

9.1 Benelux T-Cell Immunotherapy Sales and Value (2012-2017)

9.1.1 Benelux T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

9.1.2 Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

9.1.9 Benelux T-Cell Immunotherapy Sales Price Trend (2012-2017)

9.2 Benelux T-Cell Immunotherapy Sales and Market Share by Manufacturers

9.3 Benelux T-Cell Immunotherapy Sales and Market Share by Type

9.4 Benelux T-Cell Immunotherapy Sales and Market Share by Application

10 Europe T-Cell Immunotherapy Manufacturers Analysis

10.1 Adaptimmune

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 T-Cell Immunotherapy Product Type, Application and Specification

10.1.2.1 CAR-T

10.1.2.2 TCR

10.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Altor Bioscience Corporation

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 T-Cell Immunotherapy Product Type, Application and Specification

10.2.2.1 CAR-T

10.2.2.2 TCR

10.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Cellectis

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 T-Cell Immunotherapy Product Type, Application and Specification

10.3.2.1 CAR-T

10.3.2.2 TCR

10.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Cell Therapy Catapult

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 T-Cell Immunotherapy Product Type, Application and Specification

10.4.2.1 CAR-T

10.4.2.2 TCR

10.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Juno Therapeutics

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 T-Cell Immunotherapy Product Type, Application and Specification

10.5.2.1 CAR-T

10.5.2.2 TCR

10.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Kite Pharma

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 T-Cell Immunotherapy Product Type, Application and Specification

10.6.2.1 CAR-T

10.6.2.2 TCR

10.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Novartis

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 T-Cell Immunotherapy Product Type, Application and Specification

10.7.2.1 CAR-T

10.7.2.2 TCR

10.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Takara Bio

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 T-Cell Immunotherapy Product Type, Application and Specification

10.8.2.1 CAR-T

10.8.2.2 TCR

10.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Unum Therapeutics

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 T-Cell Immunotherapy Product Type, Application and Specification

10.9.2.1 CAR-T

10.9.2.2 TCR

10.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Abingworth

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 T-Cell Immunotherapy Product Type, Application and Specification

10.10.2.1 CAR-T

10.10.2.2 TCR

10.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 ARCH Venture Partners

10.12 Acorn Campus Ventures

10.13 Adaptimmune

10.14 AFA F?rs?kring

10.15 AGF Private Equity

10.16 AgonOx

10.17 Agreen Biotech

10.18 Aju IB Investment

10.19 Alaska Permanent Fund

10.20 Alexandria Ventures

10.21 Allos Therapeutics

10.22 Amgen

10.23 Applied Immune Technologies

10.24 Aquilo Capital Management

11 T-Cell Immunotherapy Manufacturing Cost Analysis

11.1 T-Cell Immunotherapy Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of T-Cell Immunotherapy

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 T-Cell Immunotherapy Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe T-Cell Immunotherapy Market Forecast (2017-2022)

14.1 Germany T-Cell Immunotherapy Sales Forecast (2017-2022)

14.2 France T-Cell Immunotherapy Sales Forecast (2017-2022)

14.3 UK T-Cell Immunotherapy Sales Forecast (2017-2022)

14.4 Russia T-Cell Immunotherapy Sales Forecast (2017-2022)

14.5 Italy T-Cell Immunotherapy Sales Forecast (2017-2022)

14.6 Spain T-Cell Immunotherapy Sales Forecast (2017-2022)

14.7 Benelux T-Cell Immunotherapy Sales Forecast (2017-2022)

14.8 Europe T-Cell Immunotherapy Sales Forecast by Type (2017-2022)

14.9 Europe T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of T-Cell Immunotherapy

Table Classification of T-Cell Immunotherapy

Figure Europe Sales Market Share of T-Cell Immunotherapy by Type in 2015

Figure CAR-T Picture

Figure TCR Picture

Figure TIL Therapies Picture

Table Application of T-Cell Immunotherapy

Figure Europe Sales Market Share of T-Cell Immunotherapy by Application in 2015

Figure Hematological Malignancies Examples

Figure Solid Tumors Examples

Figure Others Examples

Figure Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure France T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Figure Europe T-Cell Immunotherapy Sales and Growth Rate (2012-2022)

Figure Europe T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

Table Europe T-Cell Immunotherapy Sales of Key Manufacturers (2015 and 2016)

Table Europe T-Cell Immunotherapy Sales Share by Manufacturers (2015 and 2016)

Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers

Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers

Table Europe T-Cell Immunotherapy Revenue by Manufacturers (2015 and 2016)

Table Europe T-Cell Immunotherapy Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe T-Cell Immunotherapy Revenue Share by Manufacturers

Table 2016 Europe T-Cell Immunotherapy Revenue Share by Manufacturers

Table Europe T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)

Table Europe T-Cell Immunotherapy Sales Share by Type (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Type (2012-2017)

Figure Europe T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)

Table Europe T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)

Table Europe T-Cell Immunotherapy Revenue Share by Type (2012-2017)

Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)

Figure Europe T-Cell Immunotherapy Revenue Growth Rate by Type (2012-2017)

Table Europe T-Cell Immunotherapy Sales and Market Share by Countries (2012-2017)

Table Europe T-Cell Immunotherapy Sales Share by Countries (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Countries (2012-2017)

Table Europe T-Cell Immunotherapy Revenue and Market Share by Countries (2012-2017)

Table Europe T-Cell Immunotherapy Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of T-Cell Immunotherapy by Countries (2012-2017)

Table Europe T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)

Table Europe T-Cell Immunotherapy Sales Share by Application (2012-2017)

Figure Sales Market Share of T-Cell Immunotherapy by Application (2012-2017)

Figure Germany T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Germany T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Germany T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Germany T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table Germany T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table Germany T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table Germany T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table Germany T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table Germany T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure France T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure France T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure France T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table France T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table France T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table France T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table France T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table France T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table France T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure UK T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure UK T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure UK T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table UK T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table UK T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table UK T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table UK T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table UK T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table UK T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure Russia T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Russia T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Russia T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Russia T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table Russia T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table Russia T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table Russia T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table Russia T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table Russia T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure Italy T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Italy T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Italy T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Italy T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table Italy T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table Italy T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table Italy T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table Italy T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table Italy T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure Spain T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Spain T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Spain T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Spain T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table Spain T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table Spain T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table Spain T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table Spain T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table Spain T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Figure Benelux T-Cell Immunotherapy Sales and Growth Rate (2012-2017)

Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate (2012-2017)

Figure Benelux T-Cell Immunotherapy Sales Price Trend (2012-2017)

Table Benelux T-Cell Immunotherapy Sales by Manufacturers (2015 and 2016)

Table Benelux T-Cell Immunotherapy Market Share by Manufacturers (2015 and 2016)

Table Benelux T-Cell Immunotherapy Sales by Type (2015 and 2016)

Table Benelux T-Cell Immunotherapy Market Share by Type (2015 and 2016)

Table Benelux T-Cell Immunotherapy Sales by Application (2015 and 2016)

Table Benelux T-Cell Immunotherapy Market Share by Application (2015 and 2016)

Table T-Cell Immunotherapy Basic Information List

Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Adaptimmune T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Altor Bioscience Corporation Basic Information List

Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Altor Bioscience Corporation T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Cellectis Basic Information List

Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Cellectis T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Cell Therapy Catapult Basic Information List

Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Cell Therapy Catapult T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Juno Therapeutics Basic Information List

Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Juno Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Kite Pharma Basic Information List

Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Kite Pharma T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Takara Bio Basic Information List

Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Takara Bio T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Unum Therapeutics Basic Information List

Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Unum Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)

Table Abingworth Basic Information List

Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)

Table Abingworth T-Cell Immunotherapy Sales Market Share (2012-2017)

Table ARCH Venture Partners Basic Information List

Table Acorn Campus Ventures Basic Information List

Table Adaptimmune Basic Information List

Table AFA F?rs?kring Basic Information List

Table AGF Private Equity Basic Information List

Table AgonOx Basic Information List

Table Agreen Biotech Basic Information List

Table Aju IB Investment Basic Information List

Table Alaska Permanent Fund Basic Information List

Table Alexandria Ventures Basic Information List

Table Allos Therapeutics Basic Information List

Table Amgen Basic Information List

Table Applied Immune Technologies Basic Information List

Table Aquilo Capital Management Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of T-Cell Immunotherapy

Figure Manufacturing Process Analysis of T-Cell Immunotherapy

Figure T-Cell Immunotherapy Industrial Chain Analysis

Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015

Table Major Buyers of T-Cell Immunotherapy

Table Distributors/Traders List

Figure Germany T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Germany T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure France T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure France T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure UK T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure UK T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure Russia T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Russia T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure Italy T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Italy T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure Spain T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Spain T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux T-Cell Immunotherapy Sales and Growth Rate Forecast (2017-2022)

Figure Benelux T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)

Table Europe T-Cell Immunotherapy Sales Forecast by Type (2017-2022)

Table Europe T-Cell Immunotherapy Sales Forecast by Application (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370